Detalhe da pesquisa
1.
Spesolimab: A Review of the First IL-36 Blocker Approved for Generalized Pustular Psoriasis.
Ann Pharmacother
; : 10600280241252688, 2024 May 16.
Artigo
Inglês
| MEDLINE | ID: mdl-38755971
2.
Vitiligo outpatient management in the United States: findings from the 2012-2019 National Ambulatory Medical care Survey (NAMCS).
J Dermatolog Treat
; 35(1): 2311793, 2024 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-38342494